Jean-Michel Boers

Jean-Michel Boers is the CEO of Boehringer Ingelheim USA, a subsidiary of the German pharmaceutical company Boehringer Ingelheim, known for its focus on human and animal health. He was recently in the news as part of a group of pharmaceutical executives who received a letter from President Donald Trump urging them to lower drug prices in the U.S., highlighting the ongoing debate over pharmaceutical pricing and accessibility.